Cronos Group Inc
NASDAQ:CRON
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.72
3.02
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Realty Income Corp
NYSE:O
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CRON stock under the Base Case scenario is 0.77 USD. Compared to the current market price of 2.24 USD, Cronos Group Inc is Overvalued by 66%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cronos Group Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CRON cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cronos Group Inc
Balance Sheet Decomposition
Cronos Group Inc
Current Assets | 935.3m |
Cash & Short-Term Investments | 848.2m |
Receivables | 33.5m |
Other Current Assets | 53.6m |
Non-Current Assets | 155.8m |
Long-Term Investments | 24.4m |
PP&E | 38m |
Intangibles | 20.1m |
Other Non-Current Assets | 73.2m |
Current Liabilities | 33.1m |
Accounts Payable | 7.8m |
Accrued Liabilities | 24.8m |
Other Current Liabilities | 440k |
Non-Current Liabilities | -1.3m |
Other Non-Current Liabilities | -1.3m |
Earnings Waterfall
Cronos Group Inc
Revenue
|
101.8m
USD
|
Cost of Revenue
|
-85.1m
USD
|
Gross Profit
|
16.7m
USD
|
Operating Expenses
|
-84.1m
USD
|
Operating Income
|
-67.4m
USD
|
Other Expenses
|
10m
USD
|
Net Income
|
-57.4m
USD
|
Free Cash Flow Analysis
Cronos Group Inc
USD | |
Free Cash Flow | USD |
In Q2 2024, Cronos Group reported a net revenue increase of 46% to $27.8 million compared to the previous year, driven by higher cannabis sales in Canada, Israel, and other markets like Germany and the U.K. The company achieved a gross profit of $6.3 million (23% margin), a $3.2 million improvement. Adjusted EBITDA improved by $4.9 million but remained negative at $11.1 million. Key investments include a $51 million credit facility to expand the GrowCo facility. The company ended the quarter with $848 million in cash. Cronos aims to consolidate GrowCo's results in Q3, enhancing its financials and market reach【4:0†source】【4:8†source】.
What is Earnings Call?
CRON Profitability Score
Profitability Due Diligence
Cronos Group Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Cronos Group Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
CRON Solvency Score
Solvency Due Diligence
Cronos Group Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Cronos Group Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRON Price Targets Summary
Cronos Group Inc
According to Wall Street analysts, the average 1-year price target for CRON is 2.78 USD with a low forecast of 2.13 USD and a high forecast of 3.92 USD.
Dividends
Current shareholder yield for CRON is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
CRON Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.
Contact
IPO
Employees
Officers
The intrinsic value of one CRON stock under the Base Case scenario is 0.77 USD.
Compared to the current market price of 2.24 USD, Cronos Group Inc is Overvalued by 66%.